US Stock MarketDetailed Quotes

ONCSQ OncoSec Medical

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 20 16:00 ET
5.96Market Cap0.00P/E (TTM)

OncoSec Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
(Q3)Apr 30, 2022
(Q2)Jan 31, 2022
(Q1)Oct 31, 2021
(FY)Jul 31, 2021
(Q4)Jul 31, 2021
(Q3)Apr 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-18.62%7.66M
-26.31%7.31M
-23.50%37.01M
-41.40%8.13M
-8.52%9.55M
-14.60%9.42M
-23.96%9.92M
11.45%48.38M
35.98%13.88M
6.12%10.44M
Selling and administrative expenses
16.17%3.01M
-22.36%2.54M
-21.65%11.19M
-53.77%2.81M
-11.59%2.52M
22.75%2.59M
0.89%3.27M
-22.01%14.28M
125.80%6.08M
-23.70%2.85M
-General and administrative expense
16.17%3.01M
-22.36%2.54M
-21.65%11.19M
-53.77%2.81M
-11.59%2.52M
22.75%2.59M
0.89%3.27M
-22.01%14.28M
125.80%6.08M
-23.70%2.85M
Research and development costs
-31.82%4.65M
-28.25%4.77M
-24.27%25.82M
-31.74%5.32M
-7.37%7.03M
-23.44%6.83M
-32.18%6.65M
35.86%34.1M
3.76%7.79M
24.36%7.59M
Operating profit
18.62%-7.66M
26.31%-7.31M
23.50%-37.01M
41.40%-8.13M
8.52%-9.55M
14.60%-9.42M
23.96%-9.92M
-11.45%-48.38M
-35.98%-13.88M
-6.12%-10.44M
Net non-operating interest income expense
-523.39%-33.55K
-37.74%-11.08K
-31.96%-20.93K
-46.70%-4.8K
-55.95%-2.7K
-13.98%-5.38K
-31.15%-8.05K
-210.07%-15.86K
19.14%-3.27K
-1.73K
Non-operating interest expense
523.39%33.55K
37.74%11.08K
31.96%20.93K
46.70%4.8K
55.95%2.7K
13.98%5.38K
31.15%8.05K
210.07%15.86K
-19.14%3.27K
--1.73K
Other net income (expense)
273.86%839.13K
-746.96%-743.45K
-158.92%-480.8K
76.23%-79.05K
-103.41%-34.01K
-247.08%-482.66K
164.73%114.91K
183.15%816K
-191.55%-332.49K
1,965.16%997.88K
Gain on sale of security
277.84%853.76K
-768.42%-781.55K
-253.72%-509.65K
66.68%-110.31K
-202.34%-36.19K
-246.10%-480.07K
166.09%116.92K
-239.70%-144.09K
-191.94%-331.12K
132.62%35.37K
Special income (charges)
----
----
--0
--0
--0
----
----
--960.79K
--0
--960.79K
-Less:Other special charges
----
----
----
----
----
----
----
---960.79K
--0
---960.79K
Other non- operating income (expenses)
-466.63%-14.64K
1,995.42%38.1K
4,199.01%28.86K
2,392.45%31.27K
26.64%2.18K
-487.05%-2.58K
-222.63%-2.01K
-100.38%-704
-144.97%-1.36K
-96.86%1.72K
Income before tax
30.76%-6.86M
17.81%-8.06M
21.16%-37.51M
42.19%-8.22M
-1.52%-9.58M
7.46%-9.9M
25.83%-9.81M
-10.33%-47.58M
-44.35%-14.21M
4.52%-9.44M
Income tax
0.00%2.95K
0
-38.22%-3.33M
100.00%19
-216,514.85%-3.34M
103.45%2.95K
0
-176.44%-2.41M
-176.18%-2.42M
1.54K
Net income
30.75%-6.86M
17.81%-8.06M
24.33%-34.18M
30.35%-8.22M
33.84%-6.25M
7.44%-9.91M
25.83%-9.81M
-6.90%-45.17M
-31.49%-11.8M
4.51%-9.44M
Net income continuous Operations
30.75%-6.86M
17.81%-8.06M
24.33%-34.18M
30.35%-8.22M
33.84%-6.25M
7.44%-9.91M
25.83%-9.81M
-6.90%-45.17M
-31.49%-11.8M
4.51%-9.44M
Minority interest income
Net income attributable to the parent company
30.75%-6.86M
17.81%-8.06M
24.33%-34.18M
30.35%-8.22M
33.84%-6.25M
7.44%-9.91M
25.83%-9.81M
-6.90%-45.17M
-31.49%-11.8M
4.51%-9.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.75%-6.86M
17.81%-8.06M
24.33%-34.18M
30.35%-8.22M
33.84%-6.25M
7.44%-9.91M
25.83%-9.81M
-6.90%-45.17M
-31.49%-11.8M
4.51%-9.44M
Basic earnings per share
52.17%-2.65
18.33%-4.5045
36.50%-19.14
27.59%-4.62
36.00%-3.52
31.94%-5.54
48.84%-5.5155
46.48%-30.14
-16.00%-6.38
44.44%-5.5
Diluted earnings per share
52.17%-2.65
18.33%-4.5045
36.50%-19.14
27.59%-4.62
36.00%-3.52
31.94%-5.54
48.84%-5.5155
46.48%-30.14
-16.00%-6.38
44.44%-5.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022(Q3)Apr 30, 2022(Q2)Jan 31, 2022(Q1)Oct 31, 2021(FY)Jul 31, 2021(Q4)Jul 31, 2021(Q3)Apr 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -18.62%7.66M-26.31%7.31M-23.50%37.01M-41.40%8.13M-8.52%9.55M-14.60%9.42M-23.96%9.92M11.45%48.38M35.98%13.88M6.12%10.44M
Selling and administrative expenses 16.17%3.01M-22.36%2.54M-21.65%11.19M-53.77%2.81M-11.59%2.52M22.75%2.59M0.89%3.27M-22.01%14.28M125.80%6.08M-23.70%2.85M
-General and administrative expense 16.17%3.01M-22.36%2.54M-21.65%11.19M-53.77%2.81M-11.59%2.52M22.75%2.59M0.89%3.27M-22.01%14.28M125.80%6.08M-23.70%2.85M
Research and development costs -31.82%4.65M-28.25%4.77M-24.27%25.82M-31.74%5.32M-7.37%7.03M-23.44%6.83M-32.18%6.65M35.86%34.1M3.76%7.79M24.36%7.59M
Operating profit 18.62%-7.66M26.31%-7.31M23.50%-37.01M41.40%-8.13M8.52%-9.55M14.60%-9.42M23.96%-9.92M-11.45%-48.38M-35.98%-13.88M-6.12%-10.44M
Net non-operating interest income expense -523.39%-33.55K-37.74%-11.08K-31.96%-20.93K-46.70%-4.8K-55.95%-2.7K-13.98%-5.38K-31.15%-8.05K-210.07%-15.86K19.14%-3.27K-1.73K
Non-operating interest expense 523.39%33.55K37.74%11.08K31.96%20.93K46.70%4.8K55.95%2.7K13.98%5.38K31.15%8.05K210.07%15.86K-19.14%3.27K--1.73K
Other net income (expense) 273.86%839.13K-746.96%-743.45K-158.92%-480.8K76.23%-79.05K-103.41%-34.01K-247.08%-482.66K164.73%114.91K183.15%816K-191.55%-332.49K1,965.16%997.88K
Gain on sale of security 277.84%853.76K-768.42%-781.55K-253.72%-509.65K66.68%-110.31K-202.34%-36.19K-246.10%-480.07K166.09%116.92K-239.70%-144.09K-191.94%-331.12K132.62%35.37K
Special income (charges) ----------0--0--0----------960.79K--0--960.79K
-Less:Other special charges -------------------------------960.79K--0---960.79K
Other non- operating income (expenses) -466.63%-14.64K1,995.42%38.1K4,199.01%28.86K2,392.45%31.27K26.64%2.18K-487.05%-2.58K-222.63%-2.01K-100.38%-704-144.97%-1.36K-96.86%1.72K
Income before tax 30.76%-6.86M17.81%-8.06M21.16%-37.51M42.19%-8.22M-1.52%-9.58M7.46%-9.9M25.83%-9.81M-10.33%-47.58M-44.35%-14.21M4.52%-9.44M
Income tax 0.00%2.95K0-38.22%-3.33M100.00%19-216,514.85%-3.34M103.45%2.95K0-176.44%-2.41M-176.18%-2.42M1.54K
Net income 30.75%-6.86M17.81%-8.06M24.33%-34.18M30.35%-8.22M33.84%-6.25M7.44%-9.91M25.83%-9.81M-6.90%-45.17M-31.49%-11.8M4.51%-9.44M
Net income continuous Operations 30.75%-6.86M17.81%-8.06M24.33%-34.18M30.35%-8.22M33.84%-6.25M7.44%-9.91M25.83%-9.81M-6.90%-45.17M-31.49%-11.8M4.51%-9.44M
Minority interest income
Net income attributable to the parent company 30.75%-6.86M17.81%-8.06M24.33%-34.18M30.35%-8.22M33.84%-6.25M7.44%-9.91M25.83%-9.81M-6.90%-45.17M-31.49%-11.8M4.51%-9.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.75%-6.86M17.81%-8.06M24.33%-34.18M30.35%-8.22M33.84%-6.25M7.44%-9.91M25.83%-9.81M-6.90%-45.17M-31.49%-11.8M4.51%-9.44M
Basic earnings per share 52.17%-2.6518.33%-4.504536.50%-19.1427.59%-4.6236.00%-3.5231.94%-5.5448.84%-5.515546.48%-30.14-16.00%-6.3844.44%-5.5
Diluted earnings per share 52.17%-2.6518.33%-4.504536.50%-19.1427.59%-4.6236.00%-3.5231.94%-5.5448.84%-5.515546.48%-30.14-16.00%-6.3844.44%-5.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Heat List
US
Overall
Symbol
Price
% Chg

No Data